Sfoglia per AUTORE
ROSSI D
Collezione ASL Biella

  

Items : 2

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Stathis A; Pirosa MC; Orsucci L; Feugier P; Tani M; Thieblemont C; Zucca E; Luminari S; Borgo E; Ielmini N; Rossi D; Cavalli F; Bertoni F; Landi F; Spina M; Re F; Pietrantuono G; Houot R; Merli M; Devizzi L; Haioun C; Liberati AM; Celli M; Pulsoni A; Angrilli F; Occhini U; Casasnovas RO; Cartron G; Cabras MG; et alii...

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.

2019
ASL Biella
AOU Novara

Zucca E; Gaidano G; Stathis A; Rossi D; Moccia AA; Moia R; Pirosa MC; Nassi L; Winkler J; Cascione L; Margiotta Casaluci G; Conconi A; Vannata B;